ENVISAGE: Evaluation and validation of the SIGMA gamma-ray tracking detector in relevant environments

ENVISAGE:SIGMA伽马射线跟踪探测器在相关环境中的评估和验证

基本信息

  • 批准号:
    ST/Y509917/1
  • 负责人:
  • 金额:
    $ 61.97万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

ENVISAGE seeks to evaluate and validate the performance of a novel radiation detection system for locating sources of gamma-radiation, progressing from Technology Readiness Level 4 to 5. The Segmented Inverted Coaxial Germanium (SIGMA) detector is a gamma-ray tracking and imaging device designed to offer unrivalled performance over other large volume germanium detectors. This is achieved by combining digital signal processing with a unique detector design. An accurate measurement of gamma-ray interaction position and energy within the detector is key to unlocking its state-of-the-art performance.The long-term vision is to operationalise the SIGMA technology in two environments. The first is deployment of a mobile SIGMA detector array at international accelerator laboratories to address questions in nuclear structure and nuclear astrophysics, including STFC Science challenges: (A6) How do nuclear reactions power astrophysical processes and create the chemical elements and (C6) what is the nature of nuclear matter? A key example is the study of extremely exotic nuclei at international accelerator facilities, in which SIGMA will facilitate ultra-sensitive decay spectroscopy experiments by identifying low-yield events within complex and high radiation backgrounds through gamma-ray tracking. The second environment is deployment of SIGMA as a spectroscopic gamma-ray imager in nuclear decommissioning to locate, identify and quantify gamma radiation.The project has 4 objectives:1. Evaluate performance for decay spectroscopy experiments. 2. Evaluate performance for gamma-ray imaging in nuclear decommissioning.3. Enhance detector manufacturing yield.4. Develop a network of potential end users.For objective 1, the Jysväskylä Accelerator Laboratory (JYFL) has been agreed as a test site due to their strong interest in adopting SIGMA technology. JYFL has one of the most versatile and efficient systems for decay spectroscopy of exotic nuclei in the world [NUPECC Long Range Plan 2017]. Objective 2 underpins deployment of SIGMA technology at industrially relevant gamma-ray imaging scenarios, which will have societal and economic impact. Objective 3 and 4 will underpin wider market adoption through technology development and user engagement.
ENVISAGE旨在评估和验证一种用于定位伽马辐射源的新型辐射探测系统的性能,技术准备程度从4级提高到5级。分段倒置同轴锗(SIGMA)探测器是一种伽马射线跟踪和成像设备,旨在提供其他大体积锗探测器无法比拟的性能。这是通过将数字信号处理与独特的检测器设计相结合来实现的。探测器内伽马射线相互作用位置和能量的精确测量是解锁其最先进性能的关键。长期愿景是在两种环境中实施SIGMA技术。第一个是在国际加速器实验室部署移动的SIGMA探测器阵列,以解决核结构和核天体物理学问题,包括STFC科学挑战:(A6)核反应如何推动天体物理过程并产生化学元素,(C6)核物质的性质是什么?一个关键的例子是在国际加速器设施上研究极端奇异的核,其中SIGMA将通过伽马射线跟踪确定复杂和高辐射背景中的低当量事件,从而促进超灵敏衰变光谱学实验。第二个环境是部署SIGMA作为一个光谱伽马射线成像仪在核退役定位,识别和量化伽马辐射。评估衰变光谱实验的性能。2.评估伽马射线成像在核退役中的性能。提高探测器制造良率.建立潜在终端用户网络。对于目标1,由于Jysväskylä加速器实验室(JYFL)对采用SIGMA技术的浓厚兴趣,该实验室已被同意作为测试场地。JYFL拥有世界上最通用和最有效的奇异核衰变光谱系统之一[NUPECC长期计划2017]。目标2支持SIGMA技术在工业相关伽马射线成像场景中的部署,这将产生社会和经济影响。目标3和4将通过技术开发和用户参与来支持更广泛的市场采用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Joanne Harkness-Brennan其他文献

Laura Joanne Harkness-Brennan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Joanne Harkness-Brennan', 18)}}的其他基金

Accelerating the development of novel technologies for nuclear physics
加速核物理新技术发展
  • 批准号:
    ST/W005646/1
  • 财政年份:
    2022
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
Sub voxel position identification in Cadmium Zinc Telluride detectors for Low Dose Molecular Breast Imaging (small pixel camera)
用于低剂量分子乳腺成像的碲化镉锌探测器中的亚体素位置识别(小像素相机)
  • 批准号:
    ST/T003308/1
  • 财政年份:
    2020
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
STFC Cancer Diagnosis Network+
STFC癌症诊断网络
  • 批准号:
    ST/S005404/1
  • 财政年份:
    2019
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
Sub voxel position identification in Cadmium Zinc Telluride detectors for Low Dose Molecular Breast Imaging
用于低剂量分子乳腺成像的碲化镉锌探测器中的亚体素位置识别
  • 批准号:
    ST/S002723/1
  • 财政年份:
    2019
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
Mu2e : A proposal to extend the sensitivity to charged lepton flavour violation by 4 orders of magnitude.
Mu2e:一项将带电轻子风味违规的灵敏度扩大 4 个数量级的提案。
  • 批准号:
    ST/P002757/1
  • 财政年份:
    2017
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
Development of the Segmented Inverted Coaxial Germanium (SIGMA) Detector for Enhanced Gamma-Ray Spectroscopy and Imaging
开发用于增强伽马射线光谱和成像的分段倒置同轴锗 (SIGMA) 探测器
  • 批准号:
    ST/M003582/1
  • 财政年份:
    2015
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
Quantitative SPECT for dosimetry of 131I molecular radiotherapy
131I分子放射治疗剂量定量SPECT
  • 批准号:
    ST/M007847/1
  • 财政年份:
    2015
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant

相似国自然基金

基于重要农地保护LESA(Land Evaluation and Site Assessment)体系思想的高标准基本农田建设研究
  • 批准号:
    41340011
  • 批准年份:
    2013
  • 资助金额:
    20.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
Core 3 - Biomarkers and Product Evaluation
核心 3 - 生物标志物和产品评估
  • 批准号:
    10628258
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
Validation of airway remodelling by three-dimensional cellular models using healthy/asthmatic cells and evaluation of drug efficacy.
使用健康/哮喘细胞的三维细胞模型验证气道重塑并评估药物疗效。
  • 批准号:
    23K07662
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prost
PRISM 的开发、多祖先国际验证、算法审核和前瞻性静默试验评估 - 一种全球可访问、面向患者的基于人工智能的模型,用于预测具有临床意义的前列腺的存在
  • 批准号:
    479908
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Operating Grants
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
TEDI 的验证:婴儿发育的远程医疗评估。
  • 批准号:
    10805226
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
Vital capacity & airflow measurement for voice evaluation: A vortex whistle system
肺活量
  • 批准号:
    10737248
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
In vivo Evaluation of Lymph Nodes Using Quantitative Ultrasound
使用定量超声对淋巴结进行体内评估
  • 批准号:
    10737152
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
Evaluation of Food Security Scales among Hispanic Parents: A Cognitive Interview and Psychometric Properties Study
西班牙裔父母粮食安全量表评估:认知访谈和心理测量特性研究
  • 批准号:
    10741938
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
A multi-omic and integrative longitudinal evaluation of the role of lipid, antioxidant, and osmoprotectant metabolites in the genitourinary syndrome of menopause by race and ethnicity.
按种族和民族对脂质、抗氧化剂和渗透保护代谢物在更年期泌尿生殖综合征中的作用进行多组学和综合纵向评估。
  • 批准号:
    10643444
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
Evaluation of genetic variants affecting platelet function with CRISPR HDR in human megakaryocytes
利用 CRISPR HDR 评估影响人类巨核细胞血小板功能的遗传变异
  • 批准号:
    10737494
  • 财政年份:
    2023
  • 资助金额:
    $ 61.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了